Canadian biotech company Chinook Therapeutics raises $65M for rare kidney disease therapies

This post was originally published on this site
Chinook Therapeutics CEO Eric Dobmeier. (Chinook Photo)

Chinook Therapeutics, a Vancouver, B.C.-based biotech company creating targeted therapies for kidney diseases, raised $65 million in a Series A financing round led by Versant Ventures with Apple Tree Partners and Samsara BioCapital.

The company is creating precision medicines for rare

contactedorg

Check out http://contacted.org